Spermosens (Germany) Performance
| 9R5 Stock | 0 0.0002 16.67% |
Spermosens holds a performance score of 15 on a scale of zero to a hundred. The entity has a beta of 5.02, which indicates a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Spermosens will likely underperform. Use Spermosens AB market risk adjusted performance, coefficient of variation, information ratio, as well as the relationship between the mean deviation and standard deviation , to analyze future returns on Spermosens AB.
Risk-Adjusted Performance
Good
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in Spermosens AB are ranked lower than 15 (%) of all global equities and portfolios over the last 90 days. Despite nearly fragile basic indicators, Spermosens reported solid returns over the last few months and may actually be approaching a breakup point. ...more
1 | Spermosens and Sapyen sign Memorandum of Understanding to advance male fertility diagnostics - Finansavisen | 01/16/2026 |
Spermosens |
Spermosens Relative Risk vs. Return Landscape
If you would invest 0.02 in Spermosens AB on November 21, 2025 and sell it today you would earn a total of 0.12 from holding Spermosens AB or generate 600.0% return on investment over 90 days. Spermosens AB is currently producing 26.358% returns and takes up 132.9401% volatility of returns over 90 trading days. Put another way, most equities are less risky on the basis of their return distribution than Spermosens, and majority of traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
| Risk |
Spermosens Target Price Odds to finish over Current Price
The tendency of Spermosens Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 0 | 90 days | 0 | about 1.13 |
Based on a normal probability distribution, the odds of Spermosens to move above the current price in 90 days from now is about 1.13 (This Spermosens AB probability density function shows the probability of Spermosens Stock to fall within a particular range of prices over 90 days) .
Spermosens Price Density |
| Price |
Predictive Modules for Spermosens
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Spermosens AB. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Spermosens Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Spermosens is not an exception. The market had few large corrections towards the Spermosens' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Spermosens AB, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Spermosens within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 27.18 | |
β | Beta against Dow Jones | 5.02 | |
σ | Overall volatility | 0.0004 | |
Ir | Information ratio | 0.20 |
Spermosens Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Spermosens for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Spermosens AB can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Spermosens AB is way too risky over 90 days horizon | |
| Spermosens AB has some characteristics of a very speculative penny stock | |
| Spermosens AB appears to be risky and price may revert if volatility continues | |
| Spermosens AB has high likelihood to experience some financial distress in the next 2 years | |
| Net Loss for the year was (10.2 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Spermosens generates negative cash flow from operations |
Spermosens Fundamentals Growth
Spermosens Stock prices reflect investors' perceptions of the future prospects and financial health of Spermosens, and Spermosens fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Spermosens Stock performance.
| Return On Equity | -0.34 | ||||
| Return On Asset | -0.19 | ||||
| Current Valuation | 803.27 K | ||||
| Shares Outstanding | 3.17 B | ||||
| Price To Book | 0.20 X | ||||
| EBITDA | (9.28 M) | ||||
| Net Income | (10.2 M) | ||||
| Total Debt | 230 K | ||||
| Book Value Per Share | 0.01 X | ||||
| Cash Flow From Operations | (7.76 M) | ||||
| Total Asset | 31.04 M | ||||
| Retained Earnings | (91.57 M) | ||||
About Spermosens Performance
By analyzing Spermosens' fundamental ratios, stakeholders can gain valuable insights into Spermosens' financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Spermosens has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Spermosens has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Spermosens is entity of Germany. It is traded as Stock on F exchange.Things to note about Spermosens AB performance evaluation
Checking the ongoing alerts about Spermosens for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Spermosens AB help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Spermosens AB is way too risky over 90 days horizon | |
| Spermosens AB has some characteristics of a very speculative penny stock | |
| Spermosens AB appears to be risky and price may revert if volatility continues | |
| Spermosens AB has high likelihood to experience some financial distress in the next 2 years | |
| Net Loss for the year was (10.2 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Spermosens generates negative cash flow from operations |
- Analyzing Spermosens' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Spermosens' stock is overvalued or undervalued compared to its peers.
- Examining Spermosens' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Spermosens' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Spermosens' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Spermosens' stock. These opinions can provide insight into Spermosens' potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Spermosens Stock analysis
When running Spermosens' price analysis, check to measure Spermosens' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Spermosens is operating at the current time. Most of Spermosens' value examination focuses on studying past and present price action to predict the probability of Spermosens' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Spermosens' price. Additionally, you may evaluate how the addition of Spermosens to your portfolios can decrease your overall portfolio volatility.
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities |